ISOTTInternational Society on Oxygen Transport to Tissue
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Biopure Corporation (Cambridge, MA; 617-234-6826) announced that its investigational hemoglobin-based oxygen therapeutic, Hemopure (hemoglobin glutamer - 250 (bovine)), has been shown to improve tissue oxygenation and prevent tissue damage in ischemic conditions relating to hemorrhagic shock, brain hypoxia and heart attack, according to results from pharmacology studies recently reported at the 27th Annual Meeting of the International Society on Oxygen Transport to Tissue (ISOTT) at Dartmouth College (Hanover, NH).
At the ISOTT meeting, study results were presented showing the effects of low doses of Hemopure in three different animal models of hypoxia (oxygen deprivation).